My 3.5% fall in revenue without hep C and their biggest customer may be wrong, as I don't know if some of their Hep C sales are to Chemist Warehouse, and are therefore doubled up. Which adds to my disdain for their reporting. Very difficult to work out their margins/underlying earnings if CW earnings are removed, which is what I would like to know. Revenues from CW grew at about 4%, SIG ex CW shrank 11%, but Hep C vaccine was a big part of this.
Shorted it after a moments reflection, but a day or two quickie only.
Ann: Sigma 2017/2018 Full Year ASX Release, page-5
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
0.485(24.9%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.52 | $2.70 | $2.32 | $138.1M | 55.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 123400 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.44 | 1365 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
